Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metoprolol influence on exercise-induced catecholamines in healthy subjects
NCT00885651Phase 4Unknown
- Sponsor
- Rigshospitalet
- Start
- Sep 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of Cormet in heart failure (HF) (2 arms), sponsored by Rigshospitalet. Primary endpoint: Changes in stress-triggered response of catecholamines. Status: unknown.
02
Drugs
Cormet
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00885651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00885651.